Last reviewed · How we verify

NCT05999032: PR-AIR

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

Recruiting now NA Last updated 20 August 2025
What this trial tests

NA trial testing CASE in person version (High Intensity Package) in Pediatric Asthma in 480 participants. Currently enrolling.

Timeline
16 December 2024
Primary endpoint
30 November 2026
31 July 2027

Quick facts

Lead sponsorRhode Island Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment480
Start date16 December 2024
Primary completion30 November 2026
Estimated completion31 July 2027
Sites2 locations across Puerto Rico, United States

Drugs / interventions tested

Conditions studied

Sponsor

Rhode Island Hospital

Who can join

Adults 2 to 12, any sex, with Pediatric Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pediatric Asthma

Currently open trials in the same condition.

Other Rhode Island Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05999032.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing